Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
The Efficacy of Intravenous Iron for the Treatment of Anemia in Cancer Patients
Phase 2
- Conditions
- AnemiaCancer
- Interventions
- Drug: Ferinject®
- First Posted Date
- 2015-11-06
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT02599012
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Irwon-ro ,Kangnam-gu, Korea, Republic of
Genome Sequencing in Refractory Breast Cancer to Molecular Targeted Therapy and Young Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2015-11-05
- Last Posted Date
- 2017-05-01
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 350
- Registration Number
- NCT02597179
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gangnam-Gu, Korea, Republic of
Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.
Completed
- Conditions
- Colorectal Cancer
- First Posted Date
- 2015-11-01
- Last Posted Date
- 2019-12-30
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT02593591
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Seoul, Korea, Republic Of, Korea, Republic of
Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.
- Conditions
- Metastatic Cancer
- First Posted Date
- 2015-11-01
- Last Posted Date
- 2022-06-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 2000
- Registration Number
- NCT02593578
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC
Phase 2
- Conditions
- Metastatic Breast Cancer
- Interventions
- First Posted Date
- 2015-10-30
- Last Posted Date
- 2019-04-08
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 182
- Registration Number
- NCT02592746
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Genetic Alteration After Systemic Treatment in Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2015-10-30
- Last Posted Date
- 2018-01-18
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 350
- Registration Number
- NCT02591966
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients
- First Posted Date
- 2015-10-30
- Last Posted Date
- 2021-03-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT02593019
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Pemetrexed Alone as Salvage Treatment in Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy: A Phase II Single Arm Prospective Study
- First Posted Date
- 2015-10-28
- Last Posted Date
- 2022-06-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 23
- Registration Number
- NCT02588781
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Seoul, Korea, Republic Of, Korea, Republic of
Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown Primary
Phase 2
- Conditions
- Carcinoma of Unknown Primary
- Interventions
- Drug: gemcitabine/docetaxel combination
- First Posted Date
- 2015-10-28
- Last Posted Date
- 2015-10-28
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 29
- Registration Number
- NCT02590055
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Study of Pembrolizumab in Subjects With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-Line Therapy With Platinum and Fluoropyrimidine: Integration of Molecular Subtypes Through Integrative Genomic Analysis
Phase 2
Completed
- Conditions
- Gastroesophageal Junction AdenocarcinomaGastric Adenocarcinoma
- Interventions
- First Posted Date
- 2015-10-28
- Last Posted Date
- 2023-05-09
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT02589496
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath